Drug intelligence / Profile preview

Cetirizine + Salbutamol

Development stage
Unknown
Lead developer
UCB
Modality
Small Molecules
Administration
Oral
01

Overview

The combination of cetirizine and salbutamol is a therapeutic approach for respiratory conditions with both allergic and bronchoconstrictive components. **Cetirizine** is a second-generation H1-antihistamine that selectively inhibits peripheral H1 receptors, with minimal sedative effects due to reduced brain penetration. It manages symptoms of allergic conditions, including allergic asthma. **Salbutamol** (also known as albuterol) is a short-acting beta-2 adrenergic receptor agonist used for rapid bronchodilation in conditions like asthma. When used together, studies suggest: * **Synergistic Bronchodilation**: Cetirizine can enhance salbutamol's relaxant effect on bronchi. * **Additive Bronchodilatory Effect**: Clinical studies indicate an additive bronchodilatory effect without potentiation or inhibition. * **Complementary Duration**: Cetirizine may prolong bronchodilatory action beyond salbutamol's typical duration. The combination addresses both the allergic component via cetirizine's antihistamine action and bronchospasm through salbutamol's bronchodilatory effect. Fast-disintegrating tablet formulations have been developed for ease of administration, particularly for pediatric and geriatric patients.

Other names
Cetirizine and Albuterol
02

Targets

ADRB2 (β2)HRH1 (Histamine H1 Receptor)

Beyond the preview

Go deeper on Cetirizine + Salbutamol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cetirizine + Salbutamol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call